摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(dimethylamino)-1-(2-methyl-1H-imidazol-5-yl)prop-2-en-1-one

中文名称
——
中文别名
——
英文名称
(E)-3-(dimethylamino)-1-(2-methyl-1H-imidazol-5-yl)prop-2-en-1-one
英文别名
——
(E)-3-(dimethylamino)-1-(2-methyl-1H-imidazol-5-yl)prop-2-en-1-one化学式
CAS
——
化学式
C9H13N3O
mdl
——
分子量
179.22
InChiKey
IZBKLEBLCPWCQI-SNAWJCMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    49
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Imidazolo-5-YL-2anilino-pyrimidines as agents for the inhibition of the cell proliffration
    申请人:——
    公开号:US20040014776A1
    公开(公告)日:2004-01-22
    Compounds of the formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , p, q, and n are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
    该公式化合物(I):其中R1、R2、R3、R4、R5、R6、p、q和n的定义如下,并描述了其药用盐和体内可解酯。还描述了它们的制备过程以及它们作为药物的用途,特别是作为用于在温血动物(如人)中产生细胞周期抑制(抗细胞增殖)作用的药物。
  • Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
    申请人:Breault Anne Gloria
    公开号:US20060004033A1
    公开(公告)日:2006-01-05
    Compounds of the formula (I): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , p, q, and n are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
    式(I)的化合物:其中R1、R2、R3、R4、R5、R6、p、q和n的定义如内部所述,并且所述化合物的药学上可接受的盐和体内可解的酯被描述。还描述了它们的制备过程以及它们作为药物的用途,特别是作为在温血动物(如人)中产生细胞周期抑制(抗细胞增殖)效应的药物。
  • IMIDAZOLO-5-YL-2-ANILINO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF THE CELL PROLIFERATION
    申请人:AstraZeneca AB
    公开号:EP1351958A1
    公开(公告)日:2003-10-15
  • US6969714B2
    申请人:——
    公开号:US6969714B2
    公开(公告)日:2005-11-29
  • [EN] IMIDAZOLO-5-YL-2-ANILINO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF THE CELL PROLIFERATION<br/>[FR] IMIDAZOLO-5-YL-2-ANILINO-PYRIMIDINES UTILES COMME AGENTS INHIBITEURS DE LA PROLIFERATION CELLULAIRE
    申请人:ASTRAZENECA AB
    公开号:WO2002020512A1
    公开(公告)日:2002-03-14
    Compounds of the formula (I): wherein R?1, R2, R3, R4, R5, R6¿, p, q, and n are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.
查看更多